Found: 53
Select item for more details and to access through your institution.
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37806-0
- By:
- Publication type:
- Article
The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 204, n. 2, p. 299, doi. 10.1007/s10549-023-07200-x
- By:
- Publication type:
- Article
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 459, doi. 10.1007/s10549-019-05378-7
- By:
- Publication type:
- Article
Lymphoedema and health-related quality of life by early treatment in long-term survivors of breast cancer. A comparative retrospective study up to 15 years after diagnosis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
AAV‐mouse DNase I sustains long‐term DNase I expression in vivo and suppresses breast cancer metastasis.
- Published in:
- FASEB Bioadvances, 2024, v. 6, n. 10, p. 454, doi. 10.1096/fba.2024-00114
- By:
- Publication type:
- Article
Late onset toxicities associated with the use of CDK 4/6 inhibitors in hormone receptor positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) metastatic breast cancer patients: a multidisciplinary, pan-EU position paper regarding their optimal management. The GIOCONDA project
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1247270
- By:
- Publication type:
- Article
Endocrine treatment near the end of life among older women with metastatic breast cancer: a nationwide cohort study.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1223563
- By:
- Publication type:
- Article
Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1.
- Published in:
- Acta Oncologica, 2011, v. 50, n. 3, p. 329, doi. 10.3109/0284186X.2011.554435
- By:
- Publication type:
- Article
A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer.
- Published in:
- Acta Oncologica, 2011, v. 50, n. 1, p. 35, doi. 10.3109/0284186X.2010.535847
- By:
- Publication type:
- Article
Bisphosphonate treatment in primary breast cancer: Results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer.
- Published in:
- Acta Oncologica, 2008, v. 47, n. 4, p. 740, doi. 10.1080/02841860801964988
- By:
- Publication type:
- Article
Individually tailored toxicity-based 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy of metastatic breast cancer.
- Published in:
- Acta Oncologica, 2007, v. 46, n. 2, p. 165, doi. 10.1080/02841860600871087
- By:
- Publication type:
- Article
A Population-based Study on the First Forty-Eight Breast Cancer Patients Receiving Trastuzumab (Herceptin®) on a Named Patient Basis in Sweden.
- Published in:
- Acta Oncologica, 2002, v. 41, n. 3, p. 276, doi. 10.1080/02841860260088827
- By:
- Publication type:
- Article
Can Axillary Dissection be Avoided by Improved Molecular Biological Diagnosis?
- Published in:
- Acta Oncologica, 2000, v. 39, n. 3, p. 319, doi. 10.1080/028418600750013087
- By:
- Publication type:
- Article
FEC Mobilized Stem Cells for High-dose Therapy in Breast Cancer Patients.
- Published in:
- Acta Oncologica, 1999, v. 38, n. 2, p. 239, doi. 10.1080/028418699431672
- By:
- Publication type:
- Article
Characterization of Endogenous G-CSF and the Inverse Correlation to Chemotherapy-Induced Neutropenia in Patients with Breast Cancer Using Population Modeling.
- Published in:
- Pharmaceutical Research, 2014, v. 31, n. 12, p. 3390, doi. 10.1007/s11095-014-1429-9
- By:
- Publication type:
- Article
Pre-treatment levels of inflammatory markers and chemotherapy completion rates in patients with early-stage breast cancer.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 89, doi. 10.1007/s10147-022-02255-0
- By:
- Publication type:
- Article
Lessons learned from an unsuccessful decentralized clinical trial in Oncology.
- Published in:
- NPJ Digital Medicine, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s41746-024-01214-5
- By:
- Publication type:
- Article
Next generation pan-cancer blood proteome profiling using proximity extension assay.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39765-y
- By:
- Publication type:
- Article
Next generation pan-cancer blood proteome profiling using proximity extension assay.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39765-y
- By:
- Publication type:
- Article
Validation of primary and outcome data quality in a Swedish population-based breast cancer quality registry.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12073-4
- By:
- Publication type:
- Article
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00465-3
- By:
- Publication type:
- Article
Induction of p53 expression in skin by radiotherapy and UV radiation: a randomized study.
- Published in:
- 2001
- By:
- Publication type:
- journal article
The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 3, p. 490, doi. 10.1111/bcp.13477
- By:
- Publication type:
- Article
Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter Study.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2615, doi. 10.3390/cancers14112615
- By:
- Publication type:
- Article
The novel alkylating prodrug J1: diagnosis directed activity profile ex vivo and combination analyses in vitro.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 3, p. 195, doi. 10.1007/s10637-007-9092-1
- By:
- Publication type:
- Article
Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 168, n. 2, p. 349, doi. 10.1007/s10549-017-4599-4
- By:
- Publication type:
- Article
Long-term outcome in young women with breast cancer: a population-based study.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 160, n. 1, p. 131, doi. 10.1007/s10549-016-3983-9
- By:
- Publication type:
- Article
Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 138, n. 2, p. 467, doi. 10.1007/s10549-013-2457-6
- By:
- Publication type:
- Article
Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 133, n. 1, p. 367, doi. 10.1007/s10549-012-1961-4
- By:
- Publication type:
- Article
Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-48570-x
- By:
- Publication type:
- Article
Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-0603-9
- By:
- Publication type:
- Article
Effects of heavy‐load strength training during (neo‐)adjuvant chemotherapy on muscle strength, muscle fiber size, myonuclei, and satellite cells in women with breast cancer.
- Published in:
- FASEB Journal, 2024, v. 38, n. 13, p. 1, doi. 10.1096/fj.202400634R
- By:
- Publication type:
- Article
Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 8, p. 1337, doi. 10.1007/s00259-017-3650-3
- By:
- Publication type:
- Article
Human Epidermal Growth Factor Receptor 2–Targeting [ <sup>68</sup>Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1364, doi. 10.2967/jnumed.122.265364
- By:
- Publication type:
- Article
Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule <sup>68</sup>Ga-ABY-025 in Breast Cancer Patients.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 6, p. 867, doi. 10.2967/jnumed.115.169342
- By:
- Publication type:
- Article
Multicenter Reproducibility of <sup>18</sup>F-Fluciclatide PET Imaging in Subjects with Solid Tumors.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 12, p. 1855, doi. 10.2967/jnumed.115.158253
- By:
- Publication type:
- Article
First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the <sup>111</sup>In-ABY-025 Affibody Molecule.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 5, p. 730, doi. 10.2967/jnumed.113.131243
- By:
- Publication type:
- Article
Limited inter-occasion variability in relation to inter-individual variability in chemotherapy-induced myelosuppression.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 839, doi. 10.1007/s00280-009-1089-3
- By:
- Publication type:
- Article
Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer: A Secondary Analysis of the SOLD Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2429772, doi. 10.1001/jamanetworkopen.2024.29772
- By:
- Publication type:
- Article
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Current treatment landscape of HR+/HER2− advanced breast cancer in the Nordics: a modified Delphi study.
- Published in:
- Acta Oncologica, 2023, v. 62, n. 12, p. 1680, doi. 10.1080/0284186X.2023.2254475
- By:
- Publication type:
- Article
Outcome of different radiotherapy strategies after breast conserving surgery in patients with ductal carcinoma in situ (DCIS).
- Published in:
- Acta Oncologica, 2023, v. 62, n. 9, p. 1045, doi. 10.1080/0284186X.2023.2245552
- By:
- Publication type:
- Article
Use of classifiers to optimise the identification and characterisation of metastatic breast cancer in a nationwide administrative registry.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 12, p. 1604, doi. 10.1080/0284186X.2021.1979645
- By:
- Publication type:
- Article
Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000–1.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 7, p. 825, doi. 10.1080/0284186X.2020.1757149
- By:
- Publication type:
- Article
Good adherence to adjuvant endocrine therapy in early breast cancer - a population-based study based on the Swedish Prescribed Drug Register.
- Published in:
- Acta Oncologica, 2018, v. 57, n. 7, p. 935, doi. 10.1080/0284186X.2018.1442932
- By:
- Publication type:
- Article
Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifen.
- Published in:
- Acta Oncologica, 2017, v. 56, n. 4, p. 614, doi. 10.1080/0284186X.2016.1273547
- By:
- Publication type:
- Article
Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX).
- Published in:
- Acta Oncologica, 2014, v. 53, n. 2, p. 186, doi. 10.3109/0284186X.2013.820840
- By:
- Publication type:
- Article
Does exercise intensity matter for fatigue during (neo‐)adjuvant cancer treatment? The Phys‐Can randomized clinical trial.
- Published in:
- Scandinavian Journal of Medicine & Science in Sports, 2021, v. 31, n. 5, p. 1144, doi. 10.1111/sms.13930
- By:
- Publication type:
- Article